Xatmep
NDC 52652-2001, Methotrexate, solution, from Azurity Pharmaceuticals, Inc..
- Product NDC
- 52652-2001
- Status
- Listed
- Labeler
- Azurity Pharmaceuticals, Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208400
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52652-2001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHOTREXATE2.5 mg/mL
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52652-2001-1 | 52652200101 | 120 mL in 1 BOTTLE (52652-2001-1) |
| 52652-2001-6 | 52652200106 | 60 mL in 1 BOTTLE (52652-2001-6) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/aec9984e-34c5-481b-b6bf-9bb5caf1daf8Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=52652-2001NADAC price for package 52652200106
GET /v1/drugs/nadac/52652200106
Use it
Look up 52652-2001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52652-2001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52652-2001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.